Recruiting
Phase 2

Superenhancer Inhibitor Minnelide in Advanced Refractory Adenosquamous Carcinoma of the Pancreas (ASCP)

Sponsor:

National Cancer Institute (NCI)

Code:

NCT04896073

Conditions

Adenosquamous Carcinoma of the Pancreas

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Minnelide

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information